Related Experiment Video
Updated: Nov 23, 2025
09:32
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
12.7K
MicroRNAs in temporal lobe epilepsy: a systematic review
Ali A Asadi-Pooya1,2, Amir Tajbakhsh3, Amir Savardashtaki3,4
1Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. aliasadipooya@yahoo.com.
Summary
Researchers reviewed microRNAs as biomarkers for drug-resistant temporal lobe epilepsy (TLE). While some microRNAs show potential, current evidence is not robust enough for clinical use in diagnosing TLE.
Area of Science:
- Biomarker discovery
- Epilepsy research
- Molecular diagnostics
Background:
- Approximately 30% of epilepsy patients experience drug-resistant seizures.
- Temporal lobe epilepsy (TLE) is a common form of epilepsy, often associated with drug resistance.
Purpose of the Study:
- To systematically review the evidence on microRNAs as potential biomarkers for drug-resistant TLE.
- To assess the current state of research regarding microRNA utility in diagnosing difficult-to-treat TLE.
Main Methods:
- Systematic literature search of MEDLINE (PubMed) and Scopus databases.
- Keywords used: "microRNA" AND "temporal lobe epilepsy."
- Inclusion criteria: English language, human studies on epilepsy.
Main Results:
- 16 articles were identified concerning microRNAs in TLE patient serum.
- Three studies investigated specific microRNAs (miR-155, miR-129-2-3p, miR-153) as biomarkers for drug-resistant TLE.
- Evidence quality ranged from Class II to Class III, indicating limited robustness.
Conclusions:
- Limited evidence suggests circulating serum microRNAs may serve as biomarkers for drug-resistant TLE.
- Current evidence is not yet robust enough for clinical application in diagnosing drug-resistant TLE.
- Further research is needed to overcome challenges before clinical translation of microRNA biomarkers for TLE.
